Purpose Volume of distribution is an important pharmacokinetic parameter in the distribution and half-life of a drug. Protein binding and lipid partitioning together determine drug distribution.
C l
Concentration of lipid-associated drug C p Drug concentration in the plasma C pb
Concentration of drug bound to plasma proteins in the plasma C tb
Concentration of drug bound to plasma proteins in the tissue C u
Concentration of unbound drug f um Fraction unbound in microsomal incubation f up Unbound fraction in plasma IVIVC
In vitro in vivo correlation K L Association constant for drug binding to the lipid K p
Tissue partition constant L Amount of lipid in the tissue PBPK Physiologically based pharmacokinetic models pKa,a and pKa,b pKa values for acids and bases are respectively
PLS
Partial least squares R 1 Ratio of the concentration of plasma proteins in the tissue to the concentration of plasma proteins in the plasma V ss Steady-state volume of distribution of a drug V t
Tissue volume
INTRODUCTION
Predicted pharmacokinetic properties play a large role in selecting drug candidates. It is unlikely that a compound will enter a drug development program without some knowledge of its pharmacokinetic properties. The two most important factors that determine the plasma concentration-time profile are the clearance and volume of distribution (1, 2) . The steadystate volume of distribution (V ss ) is the most useful parameter to describe drug distribution, and can be impacted by plasma protein binding, permeability, partitioning, and active transport. Drug distribution parameters are important components
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of both compartmental and physiologically based pharmacokinetic (PBPK) models. Compartmental PK models define volumes as mathematical empirical terms to convert amounts to concentrations, whereas PBPK models use partition coefficients and tissue volumes to describe drug distribution. The Oie-Tozer equation was the first physiological model for volume of distribution of drugs and remains a simple and useful standard (3) . This model states that prediction of volume of distribution requires knowledge of drug plasma protein binding and tissue partitioning. It is understood that tissue partitioning will depend upon the physicochemical characteristics of a drug molecule, and numerous studies have been published with models for the prediction of drug tissue or membrane partitioning, with subsequent prediction of volume of distribution. For example, Lombardo et al. (4, 5) used the rearranged form of the Oie-Tozer equation to calculate f ut (free fraction of drug in tissue) for neutral and basic drugs using experimental LogD, fraction ionized at pH 7.4, and plasma protein binding (f up ). Acidic drugs were not included in this work, and V ss was predicted for 18 neutral and basic compounds with a mean 2.26-fold error. Importantly, even if calculated LogD and pKa are used, experimental f up data are necessary for the f ut prediction with Lombardo's method.
Another approach to predict tissue partitioning and V ss is provided within the framework of PBPK models (6) (7) (8) (9) (10) (11) (12) . A summary of the accuracy of these approaches to predict V ss has been recently published (13) . These models use a 'bottomup' approach to predict drug disposition. Thus, tissue lipid composition, f up , blood:plasma ratio (BP), pKa and LogP are used to predict tissue partitioning. Lipid composition is characterized by three lipid categories: neutral lipids, neutral phospholipids, and acidic phospholipids. The following assumptions are made: The original Poulin method models partitioning into the neutral lipid fraction with the vegetable oil:water partition coefficient (usually calculated from LogP) and assumes that phospholipids can be represented as 30% neutral lipids and 70% water (14) . Only unionized drugs are assumed to bind to neutral lipids. A more recent unified algorithm (12) and the methods of Rodgers et al. (8) (9) (10) assume that cationic molecules bind only to acidic phospholipids. Partitioning into acidic phospholipids is modeled with BP and f up . Although these methods are purported to be based on first principles only, the underlying assumptions and approaches suggest that these models are actually semi-empirical in nature.
Since microsomes are essentially unsorted phospholipid membranes and since the primary determinants of distribution are plasma protein binding and lipid partitioning, we explored the possibility of using f um to represent tissue lipid partitioning in a model for V ss . Thus, the goal of the overall work was to develop simple models for V ss prediction with experimental f up and f um input. Next, predicted f um values from Part 1 of this work were used to predict V ss . The results of these studies are presented here.
METHODS
Development of the V ss Model. Similar to the approach by Oie and Tozer that considers intracellular, extracellular, and plasma compartments (3), we use the simple two compartment model (plasma and tissue) shown in Fig. 1 . In this model, plasma proteins exist in both the vascular (plasma) and extravascular (tissue) space. Unbound drug in the plasma is at equilibrium with drug bound to plasma protein and with free drug in the tissue. The free drug in tissue can bind to extravascular plasma proteins (P) and to lipids (L). Additionally, binding to neutral lipids and lysosomes is represented by the dashed arrows. The model without neutral lipids and lysosomal partitioning was derived as follows. As described by Rowland and Tozer (2), a plasma-tissue model can be described with Eq. 1:
V P is the plasma volume, V t is the tissue volume, C p is the concentration in the plasma, and C t is the concentration in the tissue. Substituting for bound and unbound components of plasma and tissue gives Eq. 2.
In Eq. 2, C u is the concentration of unbound drug, C pb is the concentration of drug bound to plasma proteins in the plasma, C tb is the concentration of drug bound to plasma proteins in the tissue, and C l is the concentration of lipidassociated drug. Equation 3 can be derived using the following relationships: f up = C u /(C u + C bp ); R 1 = P t /P p = C tb /C pb ; C l = C u LK L , where f up is the unbound fraction in plasma, R 1 is the ratio of the concentration of plasma proteins in the tissue to the concentration of plasma proteins in the plasma, L is the amount of lipid in the tissue, and K L is the association constant for drug binding to the lipid. R 1 is analogous to R E/I in the Oie-Tozer Eq. (3) with the exception that R 1 is based on protein concentration and R E/I is based on protein amounts.
Volumes and plasma protein levels were used as described by Rowland and Tozer (2), with V p = 0.043 L/kg, V t = 0.557 L/kg. R 1 is calculated to be 0.116 for neutral and acidic compounds (60% extraplasma albumin in 0.557 L/kg divided by 40% plasma albumin in 0.043 L/kg). An R1 value of 0.052 was used for basic drugs that are expected to bind to α-acid glycoprotein, AAG (40% extraplasma AAG in 0.557 L/kg divided by 60% plasma AAG in 0.043 L/kg).
In order to use the fraction unbound in microsomes as a measure of LK L, we assume that LK L is proportional to (1-f um )/f um :
In Eq. 4, c is the proportionality constant that relates microsomal membrane partitioning to the partitioning of drug into the tissue membranes. Combining V t and c in the last term to give the constant a gives Eq. 5:
If the relationship between microsomal partitioning in vitro and partitioning in vivo is linear instead of simply proportional, a constant b can be added to the last term in Eq. 5 to give Eq. 6.
Accounting for pH differences inside versus outside the cell, Eq. 6 can be further revised to include the unionized fraction of drug entering the cell, as follows (Eq. 7).
Where X = 1 + 10 pKa,b − pHiw + 10 pKiw − pHa,a and Y = 1 + 10 pKa,b − pHp + 10
The pH values for intracellular water and plasma are pHiw = 7.2, and pHp = 7.4, respectively.
Finally, in order to account for non-specific binding of ionized bases to acidic tissue components, a fraction ionized term can be added to Eq. 6, as shown in Eq. 8.
Equations that include binding to neutral lipids and lysosomes can be derived in an analogous manner (Eqs. 9 and 10, respectively). In Eq. 9, the neutral lipid binding is represented by LogP (13) , and lysosomal partitioning in Eq. 10 is modeled as pH partitioning terms (10a for acids and 10b for bases) (15) . Table S1 in supplementary materials further lists all the V ss models developed and tested.
For V ss model development, a subset of 63 drugs (Table S2 ) was selected, based on the availability of f up and V ss from a single meta study (16) . The careful considerations and strict calculation criteria for each V ss value of each compound are described in great detail in Obach et al. (16) . Briefly, strictly IV dosing studies were selected, and the steady state volume of distribution (as against central compartment volume or betaphase volume) was calculated with standard compartmental equations for V ss . For studies where only C-t profiles were presented but no compartmental analysis was reported, the authors in the meta-study calculated the V ss with the standard noncompartmental statistical moment equation. It is noteworthy that variation in study populations and therefore variability in V ss across populations has not been considered in this analysis. The experimental f um values are from sources provided in Part 1. The experimental f um values were normalized to 1 mg/ml microsomal protein by assuming linearity and calculating an average binding constant and predicting the value at 1 mg/ml. Due to the sensitivity of the resulting model to very low f up and f um values (see discussion), we excluded drugs with f up < 0.005. Equations 6-10 were fit to this dataset. L o g t r a n s f o r m e d e q u a t i o n s w e r e f i t u s i n g t h e NonlinearModelFit routine in Mathematica. For models that included lysosomal partitioning, the equations for acids and bases were fit simultaneously. Model selection was based on corrected Akaike Information Criteria (AICc) (17) . Outliers were identified using the BoxWhisker function in Mathematica with the upper and lower fences defined as 1.5 times the interquartile range. Finally, the best models were used to predict V ss using predicted f um values derived in Part 1.
RESULTS
For V ss prediction, a total of ten models was derived (Eqs. 6-10, Table S1 ), and the five models with the best AICc values are shown in Tables 1. The five models had essentially similar AICc values (Table 1) . Addition of a neutral lipid component, correction for fraction ionized, or addition of a lysosomal compartment did not result in a substantially lower AICc.
For models in Tables 1 and S1 , three outliers were identified: nicardipine, quinine and zidovudine. After excluding outliers, the R 2 values, average absolute fold error (AAFE), and best fit parameters for the 5 models are listed in Table 1 . In general, about 85% of the variance could be explained by all models and parameters were consistent. The linear LK L model with inclusion of neutral lipids and fraction ionized had a slightly lower AICc value (13.9), relative to the linear LK L model (AICc = 15.4). However, this difference is insufficient to distinguish between the two models. Therefore the simpler linear LK L model was selected, and the fit for this model is shown in Fig. 2a . It can be seen that 75% of the 60 drugs have predicted V ss values within 2-fold error and 92% drugs were within 3-fold. The AAFE values were 1.6 for all models. Figure 2b shows the predicted versus observed V ss values for all 63 drugs using the linear LK L model in Table 1 , with predicted f um values from Part 1. With predicted f um values, the R 2 of the V ss prediction was 0.75 with no outliers. Of the 63 drugs analyzed, 71% of drugs have predicted V ss values within 2-fold error and 86% of drugs were within 3-fold.
In addition to the model to predict f um in Part 1, other models to predict f um are available. A commonly used model predicts f um with a quadratic relationship between f um and LogP/D (18) . A dataset for which experimental f um , V ss , and LogP or LogD are available (n = 59) was used to compare the Hallifax model with the f um model in Part 1. V ss predictions 
39.6 15.4 0.84, 1.6 20.0 ± 0.2 0.76 ± 0.43 ---
39.3 15.3 0.84, 1.6 19.9 ± 2.5 0.76 ± 0.43 0 --
38.2 14.0 0.85, 1.6 18.8 ± 2.4 0.49 ± 0.40 -2.94±1.9 - using the quadratic relationship and Eq. 11 from Part 1 is shown in Fig. 3 . Using the predictions from the model in Part 1, 81% of LogV ss values were predicted within 3-fold and 71% within 2-fold error with R 2 = 0.73. Using the quadratic equation, 81% of LogV ss values were predicted within 3-fold and 58% within 2-fold error with R 2 = 0.62.
DISCUSSION
Much of the effort in preclinical drug metabolism and pharmacokinetics is focused on predicting human drug disposition. Significant progress has been made in the area of in vitro-in vivo correlations (IVIVCs). Although we have been relatively successful at predicting drug clearance from in vitro data (19) (20) (21) (22) , predicting the half-life of a drug requires an estimation of both clearance and volume. Lombardo et al. have developed quantitative structure-property relationships to predict volume of distribution (4, 5) . These models were based on the Oie-Tozer Eq. (3) and the tissue binding parameters were fit to the experimental parameters, LogD, pKa, and the unbound fraction in the plasma. More recently standard QSAR techniques were used to make a model that predicts V ss from structural descriptors (23) (24) (25) . Sui et al. has used artificial immobilized membrane partitioning coefficients, pKa, and plasma protein binding data to predict volume (26) .
In addition to models that directly predict V ss , PBPK models estimate V ss with tissue volumes and drug partition coefficients (8, 27) . Although these models are bottom-up, some of the assumptions call into question the basis of these models (see Perspective in this issue). In Part 1 of these manuscripts, we developed models to predict f um from physicochemical properties. Here, we evaluate the ability to predict V ss with a minimum set of experimental measurements. Specifically, interactions with phospholipid membranes are parameterized with microsomal partitioning (f um ), interactions with neutral lipids with LogP, and lysosomal partitioning with pKa. We compare a total of ten V ss models (Table S1 ) that include either proportional or linear relationships between microsomal partitioning and tissue partitioning. Other model components tested include: partitioning into neutral lipid (represented by LogP), lysosomal partitioning (fraction ionized in lysosomes and cytosol), cellular partitioning of ionizable drugs (fraction ionized in cells and plasma), and non-specific binding of ionizable bases to tissue acidic components (pKa of basic compounds). The use of LogP to represent neutral lipid partitioning is similar to that used by Poulin (28, 29) and Rodgers (9) in PBPK modeling. To model plasma protein binding, acids and neutrals were assumed to bind to albumin and bases were assumed to bind AAG. This assumption is a limitation because many compounds can bind to both proteins. Lysosomal sequestration was modeled using standard pH partitioning methods. Cellular partitioning between cytosol and plasma is a common component of PBPK models (8, 9) . A very good correlation between unbound V ss and the unbound partition coefficient for erythrocytes has been observed for basic drugs (30) . While the mechanisms underlying this correlation are unknown, one possibility is that bases can bind to the ample sialic acid groups on the erythrocyte membrane, and by extension, to tissue capillaries. Therefore, nonspecific binding of ionizable bases was included.
It was found that the linear LK L model was the simplest model with an AICc value of 39.6 ( Table 1) . Inclusion of terms for neutral lipids, fraction ionized, or lysosomes did not significantly improve the AICc (Table 1 ). The parameters for these models (Table 1) have consistent values for the constants a and b, and similar R 2 values. The constant a is estimated to be2 0. Multiplying the lipid amount in a microsomal incubation (~0.7 uL in a 1 mg/mL microsomal protein incubation) by 20 results in 14 mL lipid/L. This can be compared to the range of 3 to 30 mL phospholipid/L non-adipose tissue. Given the complexities of the tissues, a direct correlation may not be expected. For example, as discussed in the manuscript, lysosomal partitioning certainly occurs but is likely too covariant with the partitioning of bases into phospholipids to allow inclusion in these models.
Also, the coefficient for the lysosomal sequestration term is 0.003, representing~0.3% lysosomal volume. This is consistent with values reported previously (31, 32) . A comparison of the five models with essentially non-distinguishable AICcs (Table 1) indicates that, due to its simplicity, the linear LK L model was the most appropriate model for further analyses. The ability to explain most of the variance in V ss using only f up and f um suggests that interactions with membranes are an important determinant of V ss . The fact that the additional terms e.g. neutral lipid partitioning and lysosomal partitioning, do not reach statistical significance does not imply that these processes do not occur. Lysosomal partitioning is expected for ionizable bases, and ionizable bases are also more likely to partition into phospholipid membranes.
Likewise, hydrophobic molecules partition into both neutral lipids and phospholipids. These correlated properties might mask the individual contributions of each phenomenon. We may need to incorporate these processes for other datasets or when modeling partition coefficients for specific tissues. As more and better data become available, additional components may emerge, resulting in more complex but more accurate models.
The linear LK L model had three outliers, zidovudine, nicardipine and quinine, and lower residuals were observed for all 3 when predicted f um values were used. As discussed in Part 1, zidovudine may have an inaccurate experimental f um value. When using predicted versus experimental f um for nicardipine and quinine, the residuals were −0.37 versus −0.59, and −0.55 versus −0.7, respectively. It is interesting that quinidine, a diastereomer of quinine, was well predicted. For quinidine, the experimental and predicted f um values were similar (LK L = 0.67 and 0.8, respectively; Table S2 ). However, for quinine, the predicted LK L was 0.5 log units lower than the experimental LK L . The result is that the experimental LK L value for quinine was 13-fold higher than that for quinidine, whereas the predicted values are only 3-fold higher. Although diastereomers can have different physicochemical properties, the better V ss prediction with the predicted f um suggests that the experimental quinine f um may be inaccurate. Figure 2 shows the fits for V ss prediction with experimental (A) and predicted (B) f um values. Using the experimental f um values, there were three outliers. Of the remaining 60 drugs, 92% were within 3-fold and 75% were within 2-fold error, with an R 2 of 0.83. Using predicted f um values, there were no outliers, 86% of the predictions were within 3-fold, 71% were within 2-fold, and the R 2 was 0.75. Since these models are mechanistic with a minimum number of fitted parameters, overfitting is unlikely. The results suggest that using only two experimental inputs,~80% of the variance in V ss can be explained. However the model is very sensitive to both low f up and low f um values (Fig. 4) . Therefore V ss for compounds with very high binding to plasma proteins and/or high partitioning to membranes may be poorly predicted. Figure 4 also shows that all regions are sensitive to the value of f um except when there is very high protein binding and moderate membrane partitioning.
This model can be compared to a number of descriptorbased volume models (33) , such as QSAR models (23) (24) (25) , models based on the Oie-Tozer Eqs. (4, 5) , and tissue p a r t i t i o n i n g m o d e l s u s e d i n P B P K a p p r o a c h e s (8) (9) (10) (11) 13, 29, 34, 35) . Descriptor-based models could predict volume values within 2-fold of the observed approximately 70% of the time (23, 24) . With the PBPK approach, V ss can be calculated as the sum of the individual tissue partition constants (K p ) times their tissue volumes plus the volume of the plasma. Methods to predict K p values generally use experimental f up values and relationships involving LogP, pKa, and tissue lipid composition (8) (9) (10) (11) 13, 29, 34) . In addition, the Rodgers method to calculate K p values for bases used an experimental blood-to-plasma ratio. A recent analysis to evaluate the accuracy of the various methods showed that 63-87% of the predicted volumes were within 3-fold of the experimental values (13) . In light of these analyses, any new predictive model for V ss should have better predictability and/or greater simplicity than previous models. Including outliers, the model reported here with experimental f um values can predict 92% of V ss values within 3-fold, and 86% with predicted f um values. Therefore, the models reported here are comparable to or more predictive than previously reported approaches. More notable is the simplicity of this model.
The availability of a model to predict f um reduces the required experimental input for V ss prediction to f up , provided that estimations of LogP and pKa are available. Although models to predict f um have been reported (18, 36, 37) , a commonly used model proposes a quadratic relationship between f um and LogP or LogD (18) . A comparison of V ss predictions using the predicted f um values from the quadratic relationship and Eq. 11 in Part 1 is shown in Fig. 3 . With the f um model developed in Part 1, 81% of LogV ss values were predicted within 3-fold and 71% within 2-fold error with R 2 = 0.73. Using the quadratic equation, 81% of LogV ss values were predicted within 3-fold and 58% within 2-fold error with R 2 = 0.62. The recent models published by Poulin et al. (12,38,39 ) cannot be directly compared to the present model because Poulin's model requires an additional experimental input (blood:plasma ratio), and errors are reported as deviations from f um instead of deviations from Log LK L .
It should be noted that the models presented here are preliminary in that the experimental data used in these models came from literature sources. If plasma protein binding is not conducted in the presence of CO 2 , f up can be underestimated (40) . This, together with the large inter-laboratory variability in f um values, suggests that these models can be improved. Although the present models have only been applied to predict V ss , they can also be used in PBPK models to predict tissue partitioning. It may be necessary to develop tissuespecific models for prediction of tissue partition coefficients. This will allow for prediction of perfusion-limited distribution kinetics in addition to V ss . These studies are currently underway.
In summary, we report a simple model for V ss prediction based on f up and f um . This simple two compartment model can explain >80% of the variance in V ss . The f um and V ss models in Parts 1 and 2 of this work can be used together to predict V ss with only an experimental f up as an in vitro input. The use of f um instead of LogP to predict lipid partitioning may result in quantitatively better models to predict human drug distribution.
